Selective cyclooxygenase-2 (COX-2) inhibitors protect against breast cancer.

被引：0
|
作者：
Rahme, E [1 ]
Dasgupta, K [1 ]
Ghosn, J [1 ]
Pilote, L [1 ]
Hudson, M [1 ]
机构：
[1] McGill Univ, Montreal, PQ, Canada
来源：
ARTHRITIS AND RHEUMATISM | 2003年 / 48卷 / 12期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：3661 / 3661
页数：1
相关论文
共 50 条
  • [21] Similar reductions in the risk of human colon cancer by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors
    Randall E Harris
    Joanne Beebe-Donk
    Galal A Alshafie
    BMC Cancer, 8
  • [22] Similar reductions in the risk of human colon cancer by selective and nonselective cyclooxygenase-2 (COX-2) inhibitors
    Harris, Randall E.
    Beebe-Donk, Joanne
    Alshafie, Galal A.
    BMC CANCER, 2008, 8 (1)
  • [23] Rationale and prospects for the use of cyclooxygenase-2 (COX-2) inhibitors in colorectal cancer
    Buecher, B
    Heymann, MF
    Blottière, HM
    GASTROENTEROLOGIE CLINIQUE ET BIOLOGIQUE, 2001, 25 (11): : 967 - 978
  • [24] Effect of cyclooxygenase-2 (COX-2) inhibitors on prostate cancer cell proliferation
    Srinath, P
    Rao, PNP
    Knaus, EE
    Suresh, MR
    ANTICANCER RESEARCH, 2003, 23 (5A) : 3923 - 3928
  • [25] Pharmacophore construction of Cyclooxygenase-2 (COX-2) selective inhibitors based on QSAR models
    Gomes, Renan
    Genesi, Giovani Luiz
    Maltarollo, Vinicius
    Trossini, Gustavo
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 253
  • [26] Cyclooxygenase-2 (COX-2) is associated with lymphatic and haematogenous metastases in breast cancer
    Manning, BJ
    McGreal, G
    Harmey, J
    Relihan, N
    Kay, E
    Bouchier-Hayes, D
    Redmond, HP
    BRITISH JOURNAL OF SURGERY, 2002, 89 : 73 - 73
  • [27] Glycosylation of human cyclooxygenase-2 (COX-2) decreases the efficacy of certain COX-2 inhibitors
    Sevigny, Mary B.
    Graham, Kamara
    Ponce, Esmeralda
    Louie, Maggie C.
    Mitchell, Kylie
    PHARMACOLOGICAL RESEARCH, 2012, 65 (04) : 445 - 450
  • [28] Characterization of cyclooxygenase-2 (COX-2) expression and Her2/neu in human breast, colon, and prostate cancer.
    Koki, AT
    Harmon, J
    Woerner, BM
    Zweifel, B
    Leahy, K
    Khan, NK
    Dannenberg, AJ
    Soslow, R
    Seibert, KS
    Tsai, CS
    Masferrer, JL
    CLINICAL CANCER RESEARCH, 2000, 6 : 4486S - 4486S
  • [29] Cyclooxygenase-2 (COX-2) expression and p53 mutation in gastric cancer.
    Leung, WK
    Ng, YP
    To, KF
    Chan, FK
    Ng, EK
    Lau, TY
    Lau, JY
    Chung, SS
    Sung, JJ
    GASTROENTEROLOGY, 2000, 118 (04) : A55 - A55
  • [30] Gastrointestinal tolerability of the selective cyclooxygenase-2 (COX-2) inhibitor rofecoxib compared with nonselective COX-1 and COX-2 inhibitors in osteoarthritis
    Watson, DJ
    Harper, SE
    Zhao, PL
    Quan, H
    Bolognese, JA
    Simon, TJ
    ARCHIVES OF INTERNAL MEDICINE, 2000, 160 (19) : 2998 - 3003
12345